Trial intelligence / Profile preview

Phase I/II study of FHND9041 capsules in T790M-positive non-small cell lung cancer after progression on prior EGFR-TKI therapy

CTR20191359Phase 2Completed

Sponsor

Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

Start

Jul 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1